Search NLS News

HiLIFE Tenure Track Professor Helena Kilpinen and her group at the University of Helsinki use stem cells for studying the biological mechanisms of neurodevelopmental and other brain-related diseases. During the past ten years, scientists have learned to create induced pluripotent stem cells (iPSC) from ordinary cells by genetic reprogramming. These cells are widely used to study diseases, […]

With lack of diversity and cross-border collaborations, we not only lose out on innovation – we jeopardize our democracy and risk losing an important driving force in promoting peace. In the Academic Freedom Index Update 2022, a collaborative effort between researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and the V-Dem Institute, an overview of the state of […]

Academic freedom is a necessary, if not sufficient, condition for open research and teaching, not only in the humanities and social sciences but also in the natural and life sciences. It plays a crucial role in the conduct of science, as it allows researchers and scientists the ability to pursue knowledge, explore new ideas, and […]

Ultomiris has been recommended for marketing authorization in the European Union for the treatment of adult patients with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 antibody positive. If authorised, Ultomiris would be the first and only approved long-acting C5 complement inhibitor for the treatment of AQP4 Ab+ NMOSD in the EU, states the company. “For […]

Visiting some of the world’s foremost laboratories in the Swedish city of Lund, President Alar Karis remarked that contributing to their development significantly broadens the horizons of Estonian science, deepens cooperation between researchers and makes new study methods available to them. “Many of the methods used in contemporary science only become available when countries jointly […]

We would like to thank our readers, subscribers and collaboration partners for a fruitful first quarter 2023, and we wish you all a relaxing Easter! Until next week, here are some holiday reading, Editor’s picks:The critical role of Nordic CDMOs Contract development and manufacturing organizations are emerging as global key players within the pharmaceutical industry, […]

Monique Carter, executive vice president (EVP), Global People & Organisation, has decided to leave Novo Nordisk to pursue an external opportunity, allowing her to be closer to her family in the UK. Monique Carter joined Novo Nordisk in 2018 as senior vice president (SVP) for People & Organisation, and in 2019 she was promoted to […]

Ranibizumab biosimilar is being launched in major European markets. Ranibizumab is the first product brought to market through a strategic collaboration between STADA and Xbrane Biopharma, marking Xbrane’s first commercial launch and STADA’s first co-development asset, in its growing biosimilars portfolio. Developed and manufactured solely in Europe, ranibizumab is the sixth biosimilar marketed in Europe […]

The Roddenberry Foundation has announced the six awardees of its biennial 1.5 million USD Prize to support audacious early-stage science and technology ventures that contribute to the United Nations Development Goals (UN SDGs). The 2023 Grand Prize (1 MUSD) has been awarded to Elypta for their development of the first metabolism-based test for early cancer […]

Alligator Bioscience has announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application, allowing the company to initiate the OPTIMIZE-2 Phase 2 trial evaluating its lead asset mitazalimab in urothelial carcinoma. This open-label, multi-center study aims to assess the safety and efficacy of an immunotherapeutic combination of […]